Growth and Funding Yodawy has secured substantial Series B funding and total funding of around $41M, signaling strong investor confidence and potential for scaled partnerships and enterprise-level customer acquisition in the healthtech space.

Strong Market Presence With over 4 million prescriptions processed, 2,500+ pharmacies, 200+ corporate clients, and partnerships with 15+ insurance providers, Yodawy demonstrates extensive distribution, scale, and integration opportunities for B2B and B2C collaborations.

Strategic Partnerships Existing collaborations with insurers, healthcare providers, and insurers like AXA indicate a receptiveness to ecosystem partnerships; potential cross-sell opportunities exist with insurtechs, pharmacy chains, and employer groups.

Sustainability Angle Joint initiatives with AXA to promote digitalization and sustainability suggest a value proposition around eco-friendly and digital-first medication management that can be expanded to sustainability-minded brands and CSR-focused clients.

Technology Stack & Scalability A tech-forward platform leveraging Docker, PostgreSQL, Google Cloud, and integrations with pharmacies and insurers positions Yodawy well for selling enterprise-grade API access, custom integrations, and data-powered health services to large corporates and healthcare networks.